Dr. Shin

Robert K. Shin, M.D.

Dr. Shin received his medical degree from the University of Pennsylvania. He completed a neurology residency and a multiple sclerosis fellowship at the Hospital of the University of Pennsylvania. He also completed a fellowship in neuro-ophthalmology at the Hospital of the University of Pennsylvania and the Scheie Eye Institute before joining the faculty in both the Department of Neurology and the Department of Ophthalmology and Visual Sciences at the University of Maryland.

Dr. Shin has a special interest in visual problems associated with multiple sclerosis, including optic neuritis and double vision. Dr. Shin is involved in many clinical trials for disease modifying therapies in multiple sclerosis. He frequently lectures locally and nationally on multiple sclerosis and neuro-ophthalmologic topics, and has received multiple awards and commendations for his teaching and clinical excellence.

To make an appointment to see Dr. Shin at the Maryland Center for Multiple Sclerosis, please call 410-328-4323.

Administrative Office Address:

Maryland Center for Multiple Sclerosis Treatment and Research
110 South Paca St., Third floor
Baltimore, MD 21201
Phone 410-328-5605
Fax 410-328-5425

Patient Appointment Address:

Neurology Ambulatory Center
16 South Eutaw Street, 3rd floor
Baltimore, MD 21201
Phone 410-328-4323
Fax 410-328-1149

Education and Training:
09/87 - 05/91 B.S. Yale University (Biology), cum laude
09/91 - 05/96 M.D. University of Pennsylvania
07/96 - 06/97

Intern in Medicine
Albert Einstein Medical Center, Philadelphia
07/97 - 06/00

Resident in Neurology
Hospital of the University of Pennsylvania, Philadelphia
07/00 - 06/01


Fellow in Neuro-Ophthalmology
Hospital of the University of Pennsylvania, Philadelphia
Scheie Eye Institute, Philadelphia
07/01 - 06/02

Fellow in Multiple Sclerosis
Hospital of the University of Pennsylvania, Philadelphia
 
Certifications
05/01 - present American Board of Psychiatry and Neurology (#50095)
 
Current Appointments
07/10 - Present

Associate Professor
Departments of Neurology and Ophthalmology
University of Maryland School of Medicine
07/02 - 07/10

Assistant Professor
Departments of Neurology and Ophthalmology
University of Maryland School of Medicine

Research Activities

Principal Investigator

  • FTY-720/Fingolimod (GILENYA) for Primary Progressive MS, Novartis

  • FTY-720/Fingolimod (GILENYA) for Relapsing-Remitting MS, Novartisc

  • TYGRIS (Tysabri Global Observation Program in Safety), Biogen-Idec

  • Natalizumab (Antegren) in combination with Avonex, Biogen-Idec

  • Natalizumab (Antegren) in combination with Copaxone, Biogen-Idec

  • Sub Investigator

  • Campath versus Rebif in early MS, Ilex Pharmaceuticals

  • Copaxone 20 mg vs. 40 mg, Teva Neuroscience

  • Copaxone in Clinically Isolated Syndrome, Teva Neuroscience

  • Long Term Safety of Copaxone in MS, Teva Neuroscience

  • Avonex in combination with Copaxone in MS, NIH funded

  • Betaseron or Rebif switching to Copaxone or continuing cerrent treatment, Teva Neuroscience

  • Oral Chemokine Antagonist in MS, Merck

  • Anti IL-12 in early MS, Centocor

  • 4-AP as symptomatic management in MS, Acorda

  • Rebif vs. Copaxone, Serono

  • For more information about the Maryland Center for Multiple Sclerosis, please call 410-328-5605.

    This page was last updated: July 17, 2013

             
    Average rating (12)